Erfolgreiche Behandlung eines Checkpoint‐Inhibitor‐assoziierten bullösen Pemphigoids mit Dupilumab bei Angiosarkom: Successful treatment of checkpoint inhibitor‐associated bullous pemphigoid with dupilumab in a patient with angiosarcoma

J Dtsch Dermatol Ges. 2024 Apr;22(4):587-590. doi: 10.1111/ddg.15340_g.
[Article in German]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Hemangiosarcoma*
  • Humans
  • Pemphigoid, Bullous*

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized